Biotech Industry Intelligence
GSK liver drug wins FDA approval
GSK liver drug wins FDA approval
GSK’s recent deal to license out a rare liver disease drug just got sweeter.
The FDA on Thursday approved linerixibat to treat cholestatic itch in patients with the autoimmune liver disease primary biliary cholangitis, or … Read More